Cargando…

Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review

BACKGROUND: The SARS-CoV-2 virus elicited a major public concern worldwide since December 2019 due to the high number of infections and deaths caused by COVID-19. The Omicron variant was detected in October 2021 which evolved from the wild-type SARS-CoV-2 and was found to possess many mutations. Omi...

Descripción completa

Detalles Bibliográficos
Autores principales: Arabi, Maryam, Al-Najjar, Yousef, Sharma, Omna, Kamal, Ibtihal, Javed, Aimen, Gohil, Harsh S., Paul, Pradipta, Al-Khalifa, Aljazi M., Laws, Sa’ad, Zakaria, Dalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294418/
https://www.ncbi.nlm.nih.gov/pubmed/37365490
http://dx.doi.org/10.1186/s12879-023-08328-3
_version_ 1785063192389484544
author Arabi, Maryam
Al-Najjar, Yousef
Sharma, Omna
Kamal, Ibtihal
Javed, Aimen
Gohil, Harsh S.
Paul, Pradipta
Al-Khalifa, Aljazi M.
Laws, Sa’ad
Zakaria, Dalia
author_facet Arabi, Maryam
Al-Najjar, Yousef
Sharma, Omna
Kamal, Ibtihal
Javed, Aimen
Gohil, Harsh S.
Paul, Pradipta
Al-Khalifa, Aljazi M.
Laws, Sa’ad
Zakaria, Dalia
author_sort Arabi, Maryam
collection PubMed
description BACKGROUND: The SARS-CoV-2 virus elicited a major public concern worldwide since December 2019 due to the high number of infections and deaths caused by COVID-19. The Omicron variant was detected in October 2021 which evolved from the wild-type SARS-CoV-2 and was found to possess many mutations. Omicron exhibited high transmissibility and immune evasion as well as reduced severity when compared to the earlier variants. Although vaccinated individuals were largely protected against infections in previous waves, the high prevalence of both reinfections and breakthrough infections with Omicron was observed. The aim of this review is to understand the effectiveness of previous infection on subsequent reinfection, given its significance in driving public health policy, including vaccination prioritization and lockdown requirements. METHODS: A comprehensive literature search was conducted using several databases to target studies reporting data related to the effectiveness of the previous infection with SARS-CoV-2 in protecting against the Omicron variant. Screening of the studies, quality assessment and data extraction were conducted by two reviewers for each study. RESULTS: Only 27 studies met our inclusion criteria. It was observed that previous infection was less effective in preventing reinfections with the Omicron variant compared to the Delta variant irrespective of vaccination status. Furthermore, being fully vaccinated with a booster dose provided additional protection from the Omicron variant. Additionally, most infections caused by Omicron were asymptomatic or mild and rarely resulted in hospitalizations or death in comparison to the Delta wave. CONCLUSION: A majority of the studies reached a consensus that although previous infection provides some degree of immunity against Omicron reinfection, it is much lower in comparison to Delta. Full vaccination with two doses was more protective against Delta than Omicron. Receiving a booster dose provided additional protection against Omicron. It is therefore clear that neither vaccination nor previous infection alone provide optimal protection; hybrid immunity has shown the best results in terms of protecting against either Omicron or Delta variants. However, additional research is needed to quantify how long immunity from vaccination versus previous infection lasts and whether individuals will benefit from variant-specific vaccinations to enhance protection from infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08328-3.
format Online
Article
Text
id pubmed-10294418
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102944182023-06-28 Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review Arabi, Maryam Al-Najjar, Yousef Sharma, Omna Kamal, Ibtihal Javed, Aimen Gohil, Harsh S. Paul, Pradipta Al-Khalifa, Aljazi M. Laws, Sa’ad Zakaria, Dalia BMC Infect Dis Research BACKGROUND: The SARS-CoV-2 virus elicited a major public concern worldwide since December 2019 due to the high number of infections and deaths caused by COVID-19. The Omicron variant was detected in October 2021 which evolved from the wild-type SARS-CoV-2 and was found to possess many mutations. Omicron exhibited high transmissibility and immune evasion as well as reduced severity when compared to the earlier variants. Although vaccinated individuals were largely protected against infections in previous waves, the high prevalence of both reinfections and breakthrough infections with Omicron was observed. The aim of this review is to understand the effectiveness of previous infection on subsequent reinfection, given its significance in driving public health policy, including vaccination prioritization and lockdown requirements. METHODS: A comprehensive literature search was conducted using several databases to target studies reporting data related to the effectiveness of the previous infection with SARS-CoV-2 in protecting against the Omicron variant. Screening of the studies, quality assessment and data extraction were conducted by two reviewers for each study. RESULTS: Only 27 studies met our inclusion criteria. It was observed that previous infection was less effective in preventing reinfections with the Omicron variant compared to the Delta variant irrespective of vaccination status. Furthermore, being fully vaccinated with a booster dose provided additional protection from the Omicron variant. Additionally, most infections caused by Omicron were asymptomatic or mild and rarely resulted in hospitalizations or death in comparison to the Delta wave. CONCLUSION: A majority of the studies reached a consensus that although previous infection provides some degree of immunity against Omicron reinfection, it is much lower in comparison to Delta. Full vaccination with two doses was more protective against Delta than Omicron. Receiving a booster dose provided additional protection against Omicron. It is therefore clear that neither vaccination nor previous infection alone provide optimal protection; hybrid immunity has shown the best results in terms of protecting against either Omicron or Delta variants. However, additional research is needed to quantify how long immunity from vaccination versus previous infection lasts and whether individuals will benefit from variant-specific vaccinations to enhance protection from infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08328-3. BioMed Central 2023-06-26 /pmc/articles/PMC10294418/ /pubmed/37365490 http://dx.doi.org/10.1186/s12879-023-08328-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Arabi, Maryam
Al-Najjar, Yousef
Sharma, Omna
Kamal, Ibtihal
Javed, Aimen
Gohil, Harsh S.
Paul, Pradipta
Al-Khalifa, Aljazi M.
Laws, Sa’ad
Zakaria, Dalia
Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review
title Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review
title_full Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review
title_fullStr Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review
title_full_unstemmed Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review
title_short Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review
title_sort role of previous infection with sars-cov-2 in protecting against omicron reinfections and severe complications of covid-19 compared to pre-omicron variants: a systematic review
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294418/
https://www.ncbi.nlm.nih.gov/pubmed/37365490
http://dx.doi.org/10.1186/s12879-023-08328-3
work_keys_str_mv AT arabimaryam roleofpreviousinfectionwithsarscov2inprotectingagainstomicronreinfectionsandseverecomplicationsofcovid19comparedtopreomicronvariantsasystematicreview
AT alnajjaryousef roleofpreviousinfectionwithsarscov2inprotectingagainstomicronreinfectionsandseverecomplicationsofcovid19comparedtopreomicronvariantsasystematicreview
AT sharmaomna roleofpreviousinfectionwithsarscov2inprotectingagainstomicronreinfectionsandseverecomplicationsofcovid19comparedtopreomicronvariantsasystematicreview
AT kamalibtihal roleofpreviousinfectionwithsarscov2inprotectingagainstomicronreinfectionsandseverecomplicationsofcovid19comparedtopreomicronvariantsasystematicreview
AT javedaimen roleofpreviousinfectionwithsarscov2inprotectingagainstomicronreinfectionsandseverecomplicationsofcovid19comparedtopreomicronvariantsasystematicreview
AT gohilharshs roleofpreviousinfectionwithsarscov2inprotectingagainstomicronreinfectionsandseverecomplicationsofcovid19comparedtopreomicronvariantsasystematicreview
AT paulpradipta roleofpreviousinfectionwithsarscov2inprotectingagainstomicronreinfectionsandseverecomplicationsofcovid19comparedtopreomicronvariantsasystematicreview
AT alkhalifaaljazim roleofpreviousinfectionwithsarscov2inprotectingagainstomicronreinfectionsandseverecomplicationsofcovid19comparedtopreomicronvariantsasystematicreview
AT lawssaad roleofpreviousinfectionwithsarscov2inprotectingagainstomicronreinfectionsandseverecomplicationsofcovid19comparedtopreomicronvariantsasystematicreview
AT zakariadalia roleofpreviousinfectionwithsarscov2inprotectingagainstomicronreinfectionsandseverecomplicationsofcovid19comparedtopreomicronvariantsasystematicreview